Takara Bio USA, Inc. validates new class of spatial technology with benchmark study for cancer research First in a series of benchmarking studies shows superior performance of Trekker FX in an FFPE lung squamous cell carcinoma sample 04/20/2026 Takara Bio USA, Inc. launches certified service provider program to advance research using NGS and single-cell technologies New program matches top researc

